Login to Your Account



ICAAC Roundup


Wednesday, September 12, 2012

• PolyMedix Inc., of Radnor, Pa., presented data on its defensin-mimetic antimicrobial compounds, including results of the first Phase II study of lead compound, brilacidin (PMX-30063).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription